TRF2 Overexpression during Human Breast Carcinogenesis
TRF2 在人类乳腺癌发生过程中过度表达
基本信息
- 批准号:7091638
- 负责人:
- 金额:$ 4.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-01 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding proteinDNA damagebreast neoplasmscarcinogenesiscell proliferationchemical stabilityenzyme activityenzyme induction /repressiongene expressionhuman tissuemammary epitheliumneoplasm /cancer geneticsneoplastic transformationpostdoctoral investigatorprotein protein interactionprotein structure functionproteolysistelomerasetelomeretissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): Immortality is of primary importance to human breast carcinogenesis as a prerequisite for accumulation of neoplastic changes in breast cells. In this proposal, cultured human mammary epithelial cells (HMEC) will be used to study changes contributing to immortalization. Fully immortal HMEC and breast tumor-derived cell lines often significantly overexpress telomere-binding protein, TRF2. High levels of endogenous TRF2 may be a consequence of the cells attempting to protect their critically short telomeres from being recognized as damaged DNA during the early stages of immortalization. Up-regulated TRF2 may then facilitate proliferation by telomere protection, telomere length regulation, and cell cycle checkpoint inhibition in the face of DNA damage. The objectives of this proposal are: 1) to determine whether up-regulation of TRF2 in fully immortal HMEC correlates with changes in protein-protein interactions, increased TRF2 stability, or changes in proteolytic processing; 2) to investigate whether up-regulated TRF2 is a consequence of critically short telomeres or derepression of telomerase; and 3) to elucidate whether TRF2 overexpression leads to perturbation of the cell cycle checkpoints by sequestering DNA damage sensors ATM and ATR. Results obtained in this proposal will elucidate processes occurring during early breast carcinogenesis. These studies also hold potential to identify TRF2 overexpression as a new diagnostic marker and a possible target for therapeutic intervention in the early stages of breast carcinogenesis.
描述(由申请方提供):作为乳腺细胞中肿瘤变化积累的先决条件,永生性对人类乳腺癌发生至关重要。在这项提案中,培养的人乳腺上皮细胞(HMEC)将用于研究有助于永生化的变化。完全永生的HMEC和乳腺肿瘤来源的细胞系通常显著过表达端粒结合蛋白TRF 2。高水平的内源性TRF 2可能是细胞试图保护其非常短的端粒在永生化的早期阶段不被识别为受损DNA的结果。上调的TRF 2然后可以通过端粒保护、端粒长度调节和面对DNA损伤的细胞周期检查点抑制来促进增殖。该建议的目的是:1)确定在完全永生化的HMEC中TRF 2的上调是否与蛋白质-蛋白质相互作用的变化、TRF 2稳定性的增加或蛋白水解加工的变化相关; 2)研究上调的TRF 2是否是端粒短到临界值或端粒酶去抑制的结果;以及3)阐明TRF 2过表达是否通过隔离DNA损伤传感器ATM和ATR而导致细胞周期检查点的扰动。在这个建议中获得的结果将阐明过程中发生的早期乳腺癌。这些研究也有可能将TRF 2过表达确定为一种新的诊断标志物和乳腺癌发生早期治疗干预的可能靶点。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EKATERINA BASSETT其他文献
EKATERINA BASSETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EKATERINA BASSETT', 18)}}的其他基金
TRF2 Overexpression during Human Breast Carcinogenesis
TRF2 在人类乳腺癌发生过程中过度表达
- 批准号:
6897801 - 财政年份:2004
- 资助金额:
$ 4.88万 - 项目类别:
TRF2 Overexpression during Human Breast Carcinogenesis
TRF2 在人类乳腺癌发生过程中过度表达
- 批准号:
6793793 - 财政年份:2004
- 资助金额:
$ 4.88万 - 项目类别:
相似海外基金
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
- 批准号:
10991546 - 财政年份:2024
- 资助金额:
$ 4.88万 - 项目类别:
The shielding role of the nuclear periphery against the genetic and non-genetic consequences of DNA damage (ChromoSENSOR)
核外围对 DNA 损伤的遗传和非遗传后果的屏蔽作用 (ChromoSENSOR)
- 批准号:
EP/Y027124/1 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
Research Grant
Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability
ATR 在跨损伤合成中的作用对预防 DNA 损伤诱导的突变和染色体不稳定性的影响
- 批准号:
10634852 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
The interface of transcription, DNA damage and epigenetics: A therapeutic vulnerability of the EWS-FLI1 transcription factor
转录、DNA 损伤和表观遗传学的界面:EWS-FLI1 转录因子的治疗脆弱性
- 批准号:
10718793 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
Role of DNA damage and cellular senescence in osteoarthritis pathophysiology
DNA 损伤和细胞衰老在骨关节炎病理生理学中的作用
- 批准号:
10801026 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
Elucidation of the mechanism underlying cellular senescence and aging induced by the continuous DNA damage
阐明持续DNA损伤引起的细胞衰老和老化的机制
- 批准号:
22KJ0646 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Targeting the function of BRCA1 in the DNA damage response network.
靶向 DNA 损伤反应网络中 BRCA1 的功能。
- 批准号:
2879783 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别:
Studentship
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
TAZ 和 YAP 在 3D 基因组组织 DNA 损伤修复中的新作用以及胶质母细胞瘤的治疗耐药性
- 批准号:
10649830 - 财政年份:2023
- 资助金额:
$ 4.88万 - 项目类别: